Pacira | PCRX - EPS Earnings Per Share


Pacira reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.91 0.91 Feb/26 2026
FY2025Q3 Sep/2025 0.70 0.66 0.79 Nov/06 2025
FY2025Q2 Jun/2025 0.74 0.68 0.89 Aug/05 2025
FY2025Q1 Mar/2025 0.62 0.61 0.62 May/08 2025
FY2024Q4 Dec/2024 0.91 0.79 0.89 Feb/27 2025




Eps Change Date
Assertio Holdings USD -0.03 0.01 Sep/2024
Astellas Pharma JPY 56.04 11.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Coherus Biosciences USD -0.35 0.07 Mar/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novo Nordisk DKK 6.04 1.54 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025
Xoma USD -1.59 2.43 Sep/2024
Zoetis USD 1.48 0.22 Dec/2025